You are here

home  ›  news & media
NEWS & MEDIA
 
NEW OVARIAN CANCER DIAGNOSTIC GOING TO TRIAL
Professor John Hooper has received an MRFF grant to trial a new diagnostic for epithelial ovarian cancer.
> Read More
NEWS & MEDIA
 
GRANT A BOOST FOR BONE CANCER RESEARCH
Dr Nathalie Bock has received a CureCancer grant to find new and better ways of assessing prostate cancer when it has spread to bones.
> Read More
NEWS & MEDIA
 
USING PLACENTA STEM CELLS TO HELP BONES MEND
Scientists are preparing to trial a treatment using placental stem cells to heal fractures.
> Read More
NEWS & MEDIA
 
UNPACKING THE ROLE OF MESSENGER PROTEINS IN DISEASES
Discoveries made by Dr Andrew Brooks could improve patient outcomes for many diseases.
> Read More
NEWS & MEDIA
 
GENOMICS RESEARCH TO IMPROVE INDIGENOUS HEALTH
TRI researchers working to improve health outcomes for Aboriginal and Torres Strait Islander people.
> Read More
NEWS & MEDIA
 
MAKING TRANSLATIONAL RESEARCH EASIER IN QLD
BDHP Research Passport Agreement aims to streamline the approval process for researchers, saving them time and legal costs!
> Read More
NEWS & MEDIA
 
LATEST TRI GRANTS BOOST CANCER RESEARCH
TRI has awarded three new grants to fast-track cancer research.
> Read More
NEWS & MEDIA
 
WORLD-FIRST SALIVA TEST DETECTS HIDDEN THROAT CANCER
A saliva test developed by QUT scientists affiliated with TRI has detected early throat cancer.
> Read More
NEWS & MEDIA
 
DIRECTORS’ CHOICE SERIES LAUNCHES AT TRI
A brand new series that will provide you with insights from current and past journal editors
> Read More
NEWS & MEDIA
 
GROWTH HORMONE BOOSTS LIVER SURGERY SUCCESS
TRI-based researchers discover Growth Hormone plays an important role in increasing the success of liver surgery.
> Read More
NEWS & MEDIA
 
NEW OVARIAN AND PANCREATIC CANCER TREATMENT
Professor Hooper has developed a biomolecule which he hopes to begin trialling in patients with ovarian and pancreatic cancer.
> Read More
NEWS & MEDIA
 
PROMISING NEW DRUG FOR ACUTE MYELOID LEUKAEMIA
A new drug in clinical trials has the potential to improve the survival rate of patients with acute myeloid leukaemia.
> Read More
NEWS & MEDIA
 
MELANOMA REVEALING ITS SECRETS
Professor Nikolas Haass and his team are unlocking the secrets of melanoma cells to identify better treatments for the cancer.
> Read More
NEWS & MEDIA
 
NEW DRUG TO BEAT CHEMO RESISTANCE IN OVARIAN CANCER
In a preclinical study, researchers find low doses of a drug can overcome chemotherapy resistance in an ovarian cancer sub-type
> Read More
NEWS & MEDIA
 
SUPERCHARGING FLU VACCINE
TRI respiratory specialist leads a new clinical trial to test the benefits of fibre supplements in enhancing the flu vaccine.
> Read More
NEWS & MEDIA
 
VACCINE PATCH TRIAL SUCCESS
Vaxxas’ micro-needle patch demonstrated significantly enhanced immune response compared to vaccination by needle/syringe.
> Read More
NEWS & MEDIA
 
PARKINSON’S DISEASE LINKED TO GENE TARGETED BY BLUE-GREEN ALGAE TOXIN
Scientists have discovered a possible link between Parkinson’s disease and a gene impacted by a neurotoxin found in blue-green algae.
> Read More
NEWS & MEDIA
 
NEW BIOBANK IMPROVES BREAST CANCER RESEARCH
> Read More
NEWS & MEDIA
 
NEW DRUG COMBINATION COULD SUPPORT BETTER CANCER TREATMENTS
Researchers have identified a promising new drug combination that could significantly help the immune system target cancer cells and kill them.
> Read More
NEWS & MEDIA
 
MELANOMA RISK IN YOUNG AUSTRALIANS GOES BEYOND THE BURN
> Read More
NEWS & MEDIA
 
TRI CEO CALLS FOR EUREKA AWARD NOMINATIONS
Applications for the 2020 Australian Museum Eureka Prizes open this Wednesday!
> Read More
NEWS & MEDIA
 
TRIAL BEGINS FOR NEW THROAT CANCER TREATMENT
TRI is funding a world-first human trial into HPV throat cancer
> Read More
NEWS & MEDIA
 
SOURCE OF INFLAMMATION FOUND FOR RHEUMATOID ARTHRITIS
Researchers find new details about how joint inflammation evolves in rheumatoid arthritis, and the cells that prolong the inflammatory attack.
> Read More
NEWS & MEDIA
 
1.5 MILLION FUNDING FOR AGEING AND AGED CARE RESEARCH
The Australian Government awarded $1.5 million funding to Prof Ruth Hubbard for ageing and aged care research
> Read More